Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · IEX Real-Time Price · USD
2.070
+0.070 (3.50%)
At close: Apr 19, 2024, 4:00 PM
2.060
-0.010 (-0.48%)
After-hours: Apr 19, 2024, 7:47 PM EDT
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $234.94 million as of April 19, 2024. Its market cap has decreased by -61.67% in one year.
Market Cap
234.94M
Enterprise Value
595.89M
1-Year Change
-61.67%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $234.94M, a decrease of -41.88%. That is a compound annual growth rate of -5.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 225.40M | -6.97% |
Apr 17, 2024 | 242.30M | - |
Apr 16, 2024 | 242.30M | -2.30% |
Apr 15, 2024 | 248.00M | -1.35% |
Apr 12, 2024 | 251.40M | -7.44% |
Apr 11, 2024 | 271.60M | -1.67% |
Apr 10, 2024 | 276.20M | -0.79% |
Apr 9, 2024 | 278.40M | -1.59% |
Apr 8, 2024 | 282.90M | 3.29% |
Apr 5, 2024 | 273.90M | 4.30% |
Apr 4, 2024 | 262.60M | -2.12% |
Apr 3, 2024 | 268.30M | 0.86% |
Apr 2, 2024 | 266.00M | -1.66% |
Apr 1, 2024 | 270.50M | 0.41% |
Mar 28, 2024 | 269.40M | -1.25% |
Mar 27, 2024 | 272.80M | 5.25% |
Mar 26, 2024 | 259.20M | 0.86% |
Mar 25, 2024 | 257.00M | -2.13% |
Mar 22, 2024 | 262.60M | -7.18% |
Mar 21, 2024 | 282.90M | 1.22% |
Mar 20, 2024 | 279.50M | 1.19% |
Mar 19, 2024 | 276.20M | 10.39% |
Mar 18, 2024 | 250.20M | - |
Mar 15, 2024 | 250.20M | 3.52% |
Mar 14, 2024 | 241.70M | -5.62% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Adaptimmune Therapeutics | 242.36M |
Pyxis Oncology | 242.13M |
Puma Biotechnology | 239.35M |
AC Immune | 234.60M |
2seventy bio | 232.95M |
Conduit Pharmaceuticals | 231.09M |
Adverum Biotechnologies | 230.38M |
Sharecare | 229.92M |